• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023

    6/20/23 11:02:52 AM ET
    $ABCM
    $ACGL
    $AIG
    $ALL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Property-Casualty Insurers
    Finance
    Get the next $ABCM alert in real time by email

    Upgrades

    Tudor Pickering upgraded the previous rating for EQT Corp (NYSE:EQT) from Hold to Buy. EQT earned $1.70 in the first quarter, compared to $0.81 in the year-ago quarter. At the moment, the stock has a 52-week-high of $51.95 and a 52-week-low of $28.11. EQT closed at $39.64 at the end of the last trading period.

    According to Wells Fargo, the prior rating for Ball Corp (NYSE:BALL) was changed from Underweight to Equal-Weight. Ball earned $0.69 in the first quarter, compared to $1.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $74.34 and a 52-week-low of $46.00. Ball closed at $58.43 at the end of the last trading period.

    Morgan Stanley upgraded the previous rating for Avis Budget Group Inc (NASDAQ:CAR) from Equal-Weight to Overweight. Avis Budget Gr earned $7.72 in the first quarter, compared to $9.99 in the year-ago quarter. The current stock performance of Avis Budget Gr shows a 52-week-high of $251.26 and a 52-week-low of $131.85. Moreover, at the end of the last trading period, the closing price was at $204.29.

    According to Morgan Stanley, the prior rating for US Foods Holding Corp (NYSE:USFD) was changed from Equal-Weight to Overweight. In the first quarter, US Foods Hldg showed an EPS of $0.50, compared to $0.36 from the year-ago quarter. The stock has a 52-week-high of $42.36 and a 52-week-low of $25.55. At the end of the last trading period, US Foods Hldg closed at $41.65.

    According to Morgan Stanley, the prior rating for Baidu Inc (NASDAQ:BIDU) was changed from Equal-Weight to Overweight. In the first quarter, Baidu showed an EPS of $2.34, compared to $1.77 from the year-ago quarter. The current stock performance of Baidu shows a 52-week-high of $160.88 and a 52-week-low of $73.59. Moreover, at the end of the last trading period, the closing price was at $145.11.

    Credit Suisse upgraded the previous rating for Studio City International Holdings Ltd (NYSE:MSC) from Neutral to Outperform. In the first quarter, Studio City Intl Hldgs showed an EPS of $0.17, compared to $0.54 from the year-ago quarter.

    According to Credit Suisse, the prior rating for Melco Resorts and Entertainment Ltd (NASDAQ:MLCO) was changed from Neutral to Outperform. Melco Resorts and Enter earned $0.14 in the first quarter, compared to $0.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $14.46 and a 52-week-low of $4.70. Melco Resorts and Enter closed at $12.52 at the end of the last trading period.

    JMP Securities upgraded the previous rating for EPR Properties (NYSE:EPR) from Market Perform to Market Outperform. For the first quarter, EPR Props had an EPS of $1.26, compared to year-ago quarter EPS of $1.10. The stock has a 52-week-high of $55.90 and a 52-week-low of $33.92. At the end of the last trading period, EPR Props closed at $45.80.

    For Philip Morris International Inc (NYSE:PM), Citigroup upgraded the previous rating of Neutral to Buy. Philip Morris Intl earned $1.38 in the first quarter, compared to $1.58 in the year-ago quarter. The current stock performance of Philip Morris Intl shows a 52-week-high of $105.62 and a 52-week-low of $82.85. Moreover, at the end of the last trading period, the closing price was at $94.89.

    Keybanc upgraded the previous rating for Universal Stainless & Alloy Products Inc (NASDAQ:USAP) from Sector Weight to Overweight. In the first quarter, Universal Stainless showed an EPS of $0.06, compared to $0.18 from the year-ago quarter. The current stock performance of Universal Stainless shows a 52-week-high of $12.34 and a 52-week-low of $6.56. Moreover, at the end of the last trading period, the closing price was at $12.00.

    See all analyst ratings upgrades.

    Downgrades

    For Nike Inc (NYSE:NKE), OTR Global downgraded the previous rating of Positive to Mixed. Nike earned $0.79 in the third quarter, compared to $0.87 in the year-ago quarter. At the moment, the stock has a 52-week-high of $131.31 and a 52-week-low of $82.24. Nike closed at $113.59 at the end of the last trading period.

    For Portland General Electric Co (NYSE:POR), Guggenheim downgraded the previous rating of Buy to Neutral. Portland Gen Electric earned $0.80 in the first quarter, compared to $0.67 in the year-ago quarter. The stock has a 52-week-high of $56.26 and a 52-week-low of $41.68. At the end of the last trading period, Portland Gen Electric closed at $48.67.

    Wedbush downgraded the previous rating for Surface Oncology Inc (NASDAQ:SURF) from Outperform to Neutral. Surface Oncology earned $0.33 in the first quarter, compared to $0.13 in the year-ago quarter. At the moment, the stock has a 52-week-high of $2.14 and a 52-week-low of $0.56. Surface Oncology closed at $0.79 at the end of the last trading period.

    Baird downgraded the previous rating for Surface Oncology Inc (NASDAQ:SURF) from Outperform to Neutral. Surface Oncology earned $0.33 in the first quarter, compared to $0.13 in the year-ago quarter. The current stock performance of Surface Oncology shows a 52-week-high of $2.14 and a 52-week-low of $0.56. Moreover, at the end of the last trading period, the closing price was at $0.79.

    Morgan Stanley downgraded the previous rating for Performance Food Group Co (NYSE:PFGC) from Overweight to Equal-Weight. In the third quarter, Performance Food Gr showed an EPS of $0.83, compared to $0.51 from the year-ago quarter. The stock has a 52-week-high of $63.22 and a 52-week-low of $38.81. At the end of the last trading period, Performance Food Gr closed at $56.31.

    For Surface Oncology Inc (NASDAQ:SURF), HC Wainwright & Co. downgraded the previous rating of Buy to Neutral. Surface Oncology earned $0.33 in the first quarter, compared to $0.13 in the year-ago quarter. The current stock performance of Surface Oncology shows a 52-week-high of $2.14 and a 52-week-low of $0.56. Moreover, at the end of the last trading period, the closing price was at $0.79.

    Raymond James downgraded the previous rating for Palantir Technologies Inc (NYSE:PLTR) from Strong Buy to Outperform. In the first quarter, Palantir Technologies showed an EPS of $0.05, compared to $0.02 from the year-ago quarter. The current stock performance of Palantir Technologies shows a 52-week-high of $17.16 and a 52-week-low of $5.84. Moreover, at the end of the last trading period, the closing price was at $16.30.

    Goldman Sachs downgraded the previous rating for Gates Industrial Corp PLC (NYSE:GTES) from Buy to Neutral. Gates Industrial Corp earned $0.25 in the first quarter, compared to $0.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of $14.93 and a 52-week-low of $9.44. Gates Industrial Corp closed at $13.04 at the end of the last trading period.

    According to RBC Capital, the prior rating for Abcam PLC (NASDAQ:ABCM) was changed from Outperform to Sector Perform. NoneThe current stock performance of Abcam shows a 52-week-high of $22.54 and a 52-week-low of $12.48. Moreover, at the end of the last trading period, the closing price was at $22.31.

    Jefferies downgraded the previous rating for Milestone Pharmaceuticals Inc (NASDAQ:MIST) from Buy to Hold. For the first quarter, Milestone Pharmaceuticals had an EPS of $0.35, compared to year-ago quarter EPS of $0.33. At the moment, the stock has a 52-week-high of $9.80 and a 52-week-low of $3.10. Milestone Pharmaceuticals closed at $3.50 at the end of the last trading period.

    For Public Service Enterprise Group Inc (NYSE:PEG), Seaport Global downgraded the previous rating of Buy to Neutral. For the first quarter, Public Service Enterprise had an EPS of $1.39, compared to year-ago quarter EPS of $1.33. At the moment, the stock has a 52-week-high of $69.90 and a 52-week-low of $52.53. Public Service Enterprise closed at $62.54 at the end of the last trading period.

    See all analyst ratings downgrades.

    Initiations

    With a Buy rating, ThinkEquity initiated coverage on G Medical Innovations Holdings Ltd (NASDAQ:GMVD). The price target seems to have been set at $4.00 for G Medical Innovations. NoneThe stock has a 52-week-high of $41.30 and a 52-week-low of $0.34. At the end of the last trading period, G Medical Innovations closed at $0.38.

    Roth MKM initiated coverage on Tigo Energy Inc (NASDAQ:TYGO) with a Buy rating. The price target for Tigo Energy is set to $21.00. At the moment, the stock has a 52-week-high of $27.00 and a 52-week-low of $9.69. Tigo Energy closed at $16.20 at the end of the last trading period.

    Craig-Hallum initiated coverage on Tigo Energy Inc (NASDAQ:TYGO) with a Buy rating. The price target for Tigo Energy is set to $28.00. At the moment, the stock has a 52-week-high of $27.00 and a 52-week-low of $9.69. Tigo Energy closed at $16.20 at the end of the last trading period.

    With an Outperform rating, Baird initiated coverage on Regenxbio Inc (NASDAQ:RGNX). The price target seems to have been set at $42.00 for Regenxbio. For the first quarter, Regenxbio had an EPS of $1.53, compared to year-ago quarter EPS of $1.79. At the moment, the stock has a 52-week-high of $35.55 and a 52-week-low of $17.02. Regenxbio closed at $19.88 at the end of the last trading period.

    Wells Fargo initiated coverage on Atmus Filtration Technologies Inc (NYSE:ATMU) with an Overweight rating. The price target for Atmus Filtration Techs is set to $24.00. The stock has a 52-week-high of $22.50 and a 52-week-low of $19.10. At the end of the last trading period, Atmus Filtration Techs closed at $19.52.

    BMO Capital initiated coverage on Bravo Multinational Inc (OTC:BRVO) with an Outperform rating. The price target for Bravo Multinational is set to $5.50.

    With a Equal-Weight rating, Morgan Stanley initiated coverage on Progressive Corp (NYSE:PGR). The price target seems to have been set at $135.00 for Progressive. For the first quarter, Progressive had an EPS of $0.65, compared to year-ago quarter EPS of $1.11. The current stock performance of Progressive shows a 52-week-high of $149.87 and a 52-week-low of $108.67. Moreover, at the end of the last trading period, the closing price was at $129.99.

    Morgan Stanley initiated coverage on Marsh & McLennan Companies Inc (NYSE:MMC) with a Equal-Weight rating. The price target for Marsh & McLennan is set to $202.00. In the first quarter, Marsh & McLennan showed an EPS of $2.53, compared to $2.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of $182.67 and a 52-week-low of $143.37. Marsh & McLennan closed at $181.15 at the end of the last trading period.

    Morgan Stanley initiated coverage on RenaissanceRe Holdings Ltd (NYSE:RNR) with a Equal-Weight rating. The price target for RenaissanceRe Holdings is set to $222.00. RenaissanceRe Holdings earned $8.16 in the first quarter, compared to $3.50 in the year-ago quarter. The stock has a 52-week-high of $223.80 and a 52-week-low of $124.20. At the end of the last trading period, RenaissanceRe Holdings closed at $191.83.

    EF Hutton initiated coverage on CalciMedica Inc (NASDAQ:CALC) with a Buy rating. The price target for CalciMedica is set to $17.00.

    Morgan Stanley initiated coverage on The Hartford Financial Services Group Inc (NYSE:HIG) with a Equal-Weight rating. The price target for Hartford Finl Servs Gr is set to $71.00. In the first quarter, Hartford Finl Servs Gr showed an EPS of $1.68, compared to $1.66 from the year-ago quarter. The stock has a 52-week-high of $79.44 and a 52-week-low of $60.19. At the end of the last trading period, Hartford Finl Servs Gr closed at $71.88.

    With a Equal-Weight rating, Morgan Stanley initiated coverage on The Travelers Companies Inc (NYSE:TRV). The price target seems to have been set at $185.00 for Travelers Companies. For the first quarter, Travelers Companies had an EPS of $4.11, compared to year-ago quarter EPS of $4.22. The stock has a 52-week-high of $194.51 and a 52-week-low of $149.68. At the end of the last trading period, Travelers Companies closed at $176.75.

    Morgan Stanley initiated coverage on Chubb Ltd (NYSE:CB) with a Equal-Weight rating. The price target for Chubb is set to $192.00. For the first quarter, Chubb had an EPS of $4.41, compared to year-ago quarter EPS of $3.83. The stock has a 52-week-high of $231.37 and a 52-week-low of $173.88. At the end of the last trading period, Chubb closed at $194.94.

    Morgan Stanley initiated coverage on Willis Towers Watson PLC (NASDAQ:WTW) with a Equal-Weight rating. The price target for Willis Towers Watson is set to $251.00. In the first quarter, Willis Towers Watson showed an EPS of $2.84, compared to $2.66 from the year-ago quarter. The stock has a 52-week-high of $258.93 and a 52-week-low of $187.89. At the end of the last trading period, Willis Towers Watson closed at $235.00.

    Morgan Stanley initiated coverage on Aon PLC (NYSE:AON) with a Equal-Weight rating. The price target for Aon is set to $340.00. Aon earned $5.17 in the first quarter, compared to $4.83 in the year-ago quarter. The stock has a 52-week-high of $338.27 and a 52-week-low of $246.51. At the end of the last trading period, Aon closed at $329.38.

    With a Equal-Weight rating, Morgan Stanley initiated coverage on Allstate Corp (NYSE:ALL). The price target seems to have been set at $117.00 for Allstate. Allstate earned $1.30 in the first quarter, compared to $2.58 in the year-ago quarter. At the moment, the stock has a 52-week-high of $142.15 and a 52-week-low of $103.20. Allstate closed at $111.17 at the end of the last trading period.

    Morgan Stanley initiated coverage on American International Group Inc (NYSE:AIG) with a Equal-Weight rating. The price target for American Intl Gr is set to $57.00. For the first quarter, American Intl Gr had an EPS of $1.63, compared to year-ago quarter EPS of $1.30. The stock has a 52-week-high of $64.88 and a 52-week-low of $45.66. At the end of the last trading period, American Intl Gr closed at $57.30.

    For Confluent Inc (NASDAQ:CFLT), Wolfe Research initiated coverage, by setting the current rating at Peer Perform. Confluent earned $0.09 in the first quarter, compared to $0.19 in the year-ago quarter. At the moment, the stock has a 52-week-high of $37.51 and a 52-week-low of $16.60. Confluent closed at $34.69 at the end of the last trading period.

    For GitLab Inc (NASDAQ:GTLB), Wolfe Research initiated coverage, by setting the current rating at Peer Perform. In the first quarter, GitLab showed an EPS of $0.06, compared to $0.18 from the year-ago quarter. At the moment, the stock has a 52-week-high of $70.91 and a 52-week-low of $26.24. GitLab closed at $51.24 at the end of the last trading period.

    With a Buy rating, Redburn Partners initiated coverage on ManpowerGroup Inc (NYSE:MAN). The price target seems to have been set at $94.00 for ManpowerGroup. ManpowerGroup earned $1.61 in the first quarter, compared to $1.88 in the year-ago quarter. At the moment, the stock has a 52-week-high of $92.43 and a 52-week-low of $64.10. ManpowerGroup closed at $76.56 at the end of the last trading period.

    With an Outperform rating, Baird initiated coverage on Atmus Filtration Technologies Inc (NYSE:ATMU). The price target seems to have been set at $24.00 for Atmus Filtration Techs. At the moment, the stock has a 52-week-high of $22.50 and a 52-week-low of $19.10. Atmus Filtration Techs closed at $19.52 at the end of the last trading period.

    With a Neutral rating, Redburn Partners initiated coverage on Robert Half International Inc (NYSE:RHI). The price target seems to have been set at $76.00 for Robert Half International. Robert Half International earned $1.14 in the first quarter, compared to $1.52 in the year-ago quarter. At the moment, the stock has a 52-week-high of $89.78 and a 52-week-low of $64.65. Robert Half International closed at $73.42 at the end of the last trading period.

    With an Overweight rating, Morgan Stanley initiated coverage on Everest Re Group Ltd (NYSE:RE). The price target seems to have been set at $429.00 for Everest Re Group. Everest Re Group earned $11.31 in the first quarter, compared to $10.31 in the year-ago quarter. The stock has a 52-week-high of $395.00 and a 52-week-low of $244.67. At the end of the last trading period, Everest Re Group closed at $352.35.

    UBS initiated coverage on Molina Healthcare Inc (NYSE:MOH) with a Neutral rating. The price target for Molina Healthcare is set to $310.00. For the first quarter, Molina Healthcare had an EPS of $5.81, compared to year-ago quarter EPS of $4.90. The stock has a 52-week-high of $373.78 and a 52-week-low of $250.24. At the end of the last trading period, Molina Healthcare closed at $278.02.

    With a Neutral rating, UBS initiated coverage on Centene Corp (NYSE:CNC). The price target seems to have been set at $72.00 for Centene. Centene earned $2.11 in the first quarter, compared to $1.83 in the year-ago quarter. The current stock performance of Centene shows a 52-week-high of $98.50 and a 52-week-low of $61.34. Moreover, at the end of the last trading period, the closing price was at $65.66.

    Morgan Stanley initiated coverage on Lemonade Inc (NYSE:LMND) with an Underweight rating. The price target for Lemonade is set to $14.00. Lemonade earned $0.95 in the first quarter, compared to $1.21 in the year-ago quarter. At the moment, the stock has a 52-week-high of $32.97 and a 52-week-low of $10.29. Lemonade closed at $19.70 at the end of the last trading period.

    With an Overweight rating, Morgan Stanley initiated coverage on Arch Capital Group Ltd (NASDAQ:ACGL). The price target seems to have been set at $92.00 for Arch Capital Group. Arch Capital Group earned $1.73 in the first quarter, compared to $1.10 in the year-ago quarter. At the moment, the stock has a 52-week-high of $78.30 and a 52-week-low of $41.05. Arch Capital Group closed at $71.16 at the end of the last trading period.

    B of A Securities initiated coverage on Atmus Filtration Technologies Inc (NYSE:ATMU) with a Buy rating. The price target for Atmus Filtration Techs is set to $25.00. The current stock performance of Atmus Filtration Techs shows a 52-week-high of $22.50 and a 52-week-low of $19.10. Moreover, at the end of the last trading period, the closing price was at $19.52.

    HC Wainwright & Co. initiated coverage on Calliditas Therapeutics AB (NASDAQ:CALT) with a Buy rating. The price target for Calliditas Therapeutics is set to $60.00. Calliditas Therapeutics earned $0.33 in the first quarter, compared to $0.85 in the year-ago quarter.

    Goldman Sachs initiated coverage on Atmus Filtration Technologies Inc (NYSE:ATMU) with a Buy rating. The price target for Atmus Filtration Techs is set to $30.00. The stock has a 52-week-high of $22.50 and a 52-week-low of $19.10. At the end of the last trading period, Atmus Filtration Techs closed at $19.52.

    BMO Capital initiated coverage on Entegris Inc (NASDAQ:ENTG) with an Outperform rating. The price target for Entegris is set to $129.00. For the first quarter, Entegris had an EPS of $0.65, compared to year-ago quarter EPS of $1.06. The stock has a 52-week-high of $114.47 and a 52-week-low of $61.77. At the end of the last trading period, Entegris closed at $106.51.

    With an Outperform rating, BMO Capital initiated coverage on Element Solutions Inc (NYSE:ESI). The price target seems to have been set at $23.00 for Element Solutions. For the first quarter, Element Solutions had an EPS of $0.30, compared to year-ago quarter EPS of $0.38. The stock has a 52-week-high of $21.90 and a 52-week-low of $15.32. At the end of the last trading period, Element Solutions closed at $18.96.

    JP Morgan initiated coverage on Atmus Filtration Technologies Inc (NYSE:ATMU) with an Overweight rating. The price target for Atmus Filtration Techs is set to $28.00. The stock has a 52-week-high of $22.50 and a 52-week-low of $19.10. At the end of the last trading period, Atmus Filtration Techs closed at $19.52.

    Oppenheimer initiated coverage on Galecto Inc (NASDAQ:GLTO) with an Outperform rating. The price target for Galecto is set to $12.00. Galecto earned $0.51 in the first quarter, compared to $0.67 in the year-ago quarter. The current stock performance of Galecto shows a 52-week-high of $2.95 and a 52-week-low of $1.06. Moreover, at the end of the last trading period, the closing price was at $2.84.

    See all analyst ratings initiations.

    Get the next $ABCM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABCM
    $ACGL
    $AIG
    $ALL

    CompanyDatePrice TargetRatingAnalyst
    Palantir Technologies Inc.
    $PLTR
    2/10/2026$180.00Neutral → Buy
    Daiwa Securities
    RenaissanceRe Holdings Ltd.
    $RNR
    2/9/2026$328.00Buy → Neutral
    Citigroup
    Entegris Inc.
    $ENTG
    2/4/2026$105.00Buy → Hold
    Deutsche Bank
    Palantir Technologies Inc.
    $PLTR
    2/3/2026$205.00Hold → Buy
    HSBC Securities
    ManpowerGroup
    $MAN
    2/3/2026$42.00Hold → Buy
    Argus
    Palantir Technologies Inc.
    $PLTR
    2/3/2026$190.00Market Perform → Outperform
    Northland Capital
    Palantir Technologies Inc.
    $PLTR
    2/3/2026$200.00Neutral → Outperform
    Robert W. Baird
    Palantir Technologies Inc.
    $PLTR
    2/2/2026Mkt Perform → Outperform
    William Blair
    More analyst ratings

    $ABCM
    $ACGL
    $AIG
    $ALL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Palantir Technologies upgraded by Daiwa Securities with a new price target

    Daiwa Securities upgraded Palantir Technologies from Neutral to Buy and set a new price target of $180.00

    2/10/26 7:57:53 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    RenaissanceRe downgraded by Citigroup with a new price target

    Citigroup downgraded RenaissanceRe from Buy to Neutral and set a new price target of $328.00

    2/9/26 6:56:54 AM ET
    $RNR
    Property-Casualty Insurers
    Finance

    Entegris downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded Entegris from Buy to Hold and set a new price target of $105.00

    2/4/26 8:27:42 AM ET
    $ENTG
    Plastic Products
    Industrials

    $ABCM
    $ACGL
    $AIG
    $ALL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and CFO Walsh Keith bought $2,207 worth of shares (27 units at $81.01) and covered exercise/tax liability with 4,540 shares, decreasing direct ownership by 11% to 38,259 units (SEC Form 4)

    4 - AMERICAN INTERNATIONAL GROUP, INC. (0000005272) (Issuer)

    2/2/26 7:37:50 PM ET
    $AIG
    Life Insurance
    Finance

    Chief Executive Officer Staples William bought $124,750 worth of shares (3,276 units at $38.08), increasing direct ownership by 0.96% to 345,671 units (SEC Form 4)

    4 - Gitlab Inc. (0001653482) (Issuer)

    1/5/26 6:26:25 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Director Inglis John C bought $1,200 worth of shares (14 units at $86.47), increasing direct ownership by 0.52% to 2,681 units (SEC Form 4)

    4 - AMERICAN INTERNATIONAL GROUP, INC. (0000005272) (Issuer)

    12/31/25 4:52:41 PM ET
    $AIG
    Life Insurance
    Finance

    $ABCM
    $ACGL
    $AIG
    $ALL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bruno Julianne converted options into 129,000 shares, increasing direct ownership by 1,606% to 137,032 units (SEC Form 4)

    4 - Galecto, Inc. (0001800315) (Issuer)

    2/12/26 6:05:08 AM ET
    $GLTO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Fairmount Funds Management Llc converted options into 8,713,000 shares (SEC Form 4)

    4 - Galecto, Inc. (0001800315) (Issuer)

    2/12/26 6:03:41 AM ET
    $GLTO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Officer Grosh Chasity D sold $169,602 worth of shares (1,843 units at $92.03), decreasing direct ownership by 22% to 6,601 units (SEC Form 4)

    4 - Performance Food Group Co (0001618673) (Issuer)

    2/11/26 5:00:03 PM ET
    $PFGC
    Food Distributors
    Consumer Discretionary

    $ABCM
    $ACGL
    $AIG
    $ALL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aon Appoints Joe Peiser as CEO of Risk Capital

    DUBLIN, Feb. 12, 2026 /PRNewswire/ -- Aon plc (NYSE:AON), a leading global professional services firm, today announced the appointment of Joe Peiser as CEO of Risk Capital.  In this role, Peiser will lead Aon's Risk Capital capabilities across Commercial Risk and Reinsurance Solutions. Peiser will continue to report to Andy Marcell, CEO of Global Solutions for Aon. A search for the role of CEO of Commercial Risk is underway. Peiser's appointment reflects Aon's broader strategy to strengthen how the firm helps clients navigate increasing volatility by connecting risk with the most efficient forms of capital. Peiser's enhanced leadership role will accelerate Aon's work to deliver solutions tha

    2/12/26 8:00:00 AM ET
    $AON
    Specialty Insurers
    Finance

    The Hartford's Future Of Benefits Study: Employers Seeking Simplicity And Ease In The Face Of Increasingly Complex Landscape

    Technology is now woven throughout the benefits ecosystem, helping employers to make things easier while ensuring human support remains part of the experience Human resources (HR), employee benefits and evolving technology are converging in new ways and illustrating the need for simplicity, according to the 2026 Future of Benefits Study from The Hartford, a leading provider of employee benefits and absence management services. The study reveals that almost three-quarters (73%) of employer respondents have seen an increase in day-to-day responsibilities over the past few years. As a result, employers are looking for ‘one-stop-shop' solutions where enrollment tools, simple leave products, s

    2/12/26 8:00:00 AM ET
    $HIG
    Property-Casualty Insurers
    Finance

    Studio City International Holdings Limited Announces Unaudited Fourth Quarter 2025 Earnings

    MACAU, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE:MSC) ("Studio City" or the "Company"), a world-class integrated resort located in Cotai, Macau, today reported its unaudited financial results for the fourth quarter and full year ended December 31, 2025. Total operating revenues for the fourth quarter of 2025 were US$160.3 million, compared with US$152.9 million in the fourth quarter of 2024. The increase was primarily attributable to better performance in mass market table games operations leading to an increase in revenue from casino contract and higher non-gaming revenues. Studio City Casino generated gross gaming revenues of US$342.7 million an

    2/12/26 7:57:37 AM ET
    $MLCO
    $MSC
    Hotels/Resorts
    Consumer Discretionary

    $ABCM
    $ACGL
    $AIG
    $ALL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for TARPEYO issued to CALLIDITAS THERAPEUTICS AB

    Submission status for CALLIDITAS THERAPEUTICS AB's drug TARPEYO (ORIG-1) with active ingredient BUDESONIDE has changed to 'Approval' on 12/15/2021. Application Category: NDA, Application Number: 215935, Application Classification: Type 5 - New Formulation or New Manufacturer

    12/20/21 3:40:41 PM ET
    $CALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABCM
    $ACGL
    $AIG
    $ALL
    SEC Filings

    View All

    Gates Industrial Corporation plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Gates Industrial Corp plc (0001718512) (Filer)

    2/12/26 7:39:17 AM ET
    $GTES
    Industrial Machinery/Components
    Industrials

    SEC Form 10-K filed by The Travelers Companies Inc.

    10-K - TRAVELERS COMPANIES, INC. (0000086312) (Filer)

    2/12/26 6:51:29 AM ET
    $TRV
    Property-Casualty Insurers
    Finance

    US Foods Holding Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - US Foods Holding Corp. (0001665918) (Filer)

    2/12/26 6:48:14 AM ET
    $USFD
    Food Distributors
    Consumer Discretionary

    $ABCM
    $ACGL
    $AIG
    $ALL
    Leadership Updates

    Live Leadership Updates

    View All

    Aon Appoints Joe Peiser as CEO of Risk Capital

    DUBLIN, Feb. 12, 2026 /PRNewswire/ -- Aon plc (NYSE:AON), a leading global professional services firm, today announced the appointment of Joe Peiser as CEO of Risk Capital.  In this role, Peiser will lead Aon's Risk Capital capabilities across Commercial Risk and Reinsurance Solutions. Peiser will continue to report to Andy Marcell, CEO of Global Solutions for Aon. A search for the role of CEO of Commercial Risk is underway. Peiser's appointment reflects Aon's broader strategy to strengthen how the firm helps clients navigate increasing volatility by connecting risk with the most efficient forms of capital. Peiser's enhanced leadership role will accelerate Aon's work to deliver solutions tha

    2/12/26 8:00:00 AM ET
    $AON
    Specialty Insurers
    Finance

    Milestone Pharmaceuticals Appoints David Sandoval as General Counsel and Chief Compliance Officer

    MONTREAL and CHARLOTTE, N.C., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (NASDAQ:MIST) today announced the appointment of David Sandoval as General Counsel and Chief Compliance Officer. Mr. Sandoval's appointment comes as Milestone launches CARDAMYST™ (etripamil) nasal spray, the first and only approved self-administered treatment for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. CARDAMYST was approved by the U.S. Food and Drug Administration (FDA) on December 12, 2025. He will serve as a member of Milestone's executive leadership team and will provide business-focused legal counsel across all

    2/10/26 8:00:00 AM ET
    $MIST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tigo Energy EI Residential Solar-plus-Storage Solution Certified with Romanian Grid Operators

    With approval from Distribuție Energie Electrică România (DEER), Distribuție Oltenia, and Rețele Electrice, Tigo expands offering in one of Europe's fastest-growing residential solar markets. Tigo Energy, Inc. (NASDAQ: "TYGO") ("Tigo" or "Company"), a leading provider of intelligent solar and energy software solutions, today announced the successful certification of the Tigo EI Residential solar-plus-storage solution with Romanian distribution system operators, further expanding market reach of Tigo products across Europe. Following the successful completion of their respective grid-compliance and certification procedures with Distribuție Energie Electrică Romania (DEER), Distribuție Olte

    2/9/26 12:00:00 AM ET
    $TYGO
    Semiconductors
    Technology

    $ABCM
    $ACGL
    $AIG
    $ALL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by US Foods Holding Corp.

    SC 13G/A - US Foods Holding Corp. (0001665918) (Subject)

    12/6/24 10:11:30 AM ET
    $USFD
    Food Distributors
    Consumer Discretionary

    SEC Form SC 13D filed by CalciMedica Inc.

    SC 13D - CalciMedica, Inc. (0001534133) (Subject)

    11/26/24 6:03:55 AM ET
    $CALC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by REGENXBIO Inc.

    SC 13G/A - REGENXBIO Inc. (0001590877) (Subject)

    11/14/24 9:00:57 PM ET
    $RGNX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABCM
    $ACGL
    $AIG
    $ALL
    Financials

    Live finance-specific insights

    View All

    Melco Resorts Announces Unaudited Fourth Quarter 2025 Earnings

    MACAU, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment Limited (NASDAQ:MLCO) ("Melco Resorts" or the "Company"), a developer, owner, and operator of integrated resort facilities in Asia and Europe, today reported its unaudited financial results for the fourth quarter and full year ended December 31, 2025. Total operating revenues for the fourth quarter of 2025 were US$1.29 billion, representing an increase of approximately 9% from US$1.19 billion for the comparable period in 2024. The increase in total operating revenues was primarily attributable to the improved overall rolling chip and mass market table games performance. Operating income for the fourth quarter of 2025

    2/12/26 7:56:47 AM ET
    $MLCO
    Hotels/Resorts
    Consumer Discretionary

    Gates Industrial Reports Fourth-Quarter and Full Year 2025 Results

    DENVER, Feb. 12, 2026 /PRNewswire/ --  Fourth-Quarter 2025 Financial Summary Fourth-quarter net sales of $856.2 million, up 3.2% compared to the prior-year period, including a core sales growth of 0.6%Net income attributable to shareholders of $51.3 million, or $0.20 per diluted shareAdjusted Net Income per diluted share of $0.38Net income from continuing operations of $56.4 million, or a margin of 6.6%Adjusted EBITDA of $187.8 million, or a margin of 21.9%Repurchased approximately $105 million of sharesFull-Year 2025 Financial Summary Net sales of $3,443.2 million, representi

    2/12/26 7:30:00 AM ET
    $GTES
    Industrial Machinery/Components
    Industrials

    US Foods Reports Fourth Quarter and Fiscal Year 2025 Earnings

    For Fiscal Year 2025: Grew Net Sales 4.1% to $39.4 Billion, Net Income 36.8% to $676 Million and Diluted EPS 45.5% to $2.94 Grew Adjusted EBITDA 11.0% to $1.93 Billion and Adjusted Diluted EPS 26.3% to $3.98 Expanded Adjusted EBITDA Margin 30 Basis Points to 4.9% Repurchased $934 Million of Shares US Foods Holding Corp. (NYSE:USFD), one of the largest foodservice distributors in the United States, today announced results for the fourth quarter and full fiscal year 2025. Fourth Quarter Fiscal 2025 Highlights Total case volume increased 0.8%; independent restaurant case volume increased 4.1% Net sales increased 3.3% to $9.8 billion Gross profit increased 3.2% to $1.7 bill

    2/12/26 6:45:00 AM ET
    $USFD
    Food Distributors
    Consumer Discretionary